缩宫素团注与输注在择期剖宫产中的随机双盲临床试验(INBOX试验)
该随机双盲试验纳入121例脊麻下择期剖宫产患者,比较缩宫素团注与输注对2分钟子宫张力充足率的影响。
要点
- 缩宫素团注与输注在2分钟子宫张力充足率上无显著差异。
- 团注组失血量中位数略低但差异幅度小,临床意义有限。
- 两组患者满意度及安全性指标均相似。
核心结论
- 缩宫素团注与输注在2分钟子宫张力充足率上无统计学显著差异。
- 团注组失血量统计学更低但幅度小(上限168 mL),不太可能具有临床意义。
- 两种给药方式安全性相当。
研究设计与样本
- 随机双盲临床试验,121例脊麻下择期剖宫产患者1:1随机接受缩宫素团注或输注。
- 主要终点为2分钟子宫张力充足,次要终点包括患者满意度、达到子宫张力充足时间、定量失血量、产后出血及安全性指标。
关键数值与推荐
- Hodges-Lehmann估计失血量差值82 mL(95%CI 2-168 mL)。
临床怎么用
- 择期剖宫产中缩宫素团注或输注均可用于预防产后出血,2分钟子宫张力充足率相似。
- 团注组失血量统计学更低但幅度小,临床决策时需结合其他因素综合考量。
局限性
- 样本量有限(121例随机,115例可分析)。
- 单中心研究,外推性需谨慎。
- 失血量差异幅度小且置信区间上限接近临床无意义阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oxytocin is the most widely used uterotonic for postpartum hemorrhage prevention, yet high-quality data comparing bolus versus infusion administration are limited. Given the very high uterine blood flow at term, rapid achievement of uterine tone is critical to minimize blood loss. We hypothesized that bolus administration leads to a greater likelihood of attaining adequate uterine tone at 2 minutes. METHODS: In this randomized, double-blinded clinical trial, 121 patients undergoing elective cesarean delivery under spinal anesthesia were randomized 1:1 to receive oxytocin by bolus or infusion after cord clamping. Masked study drugs were prepared by the investigational pharmacy to maintain blinding of the anesthesiologist, obstetrician, and study personnel. The primary end point was adequate uterine tone at 2 minutes. Secondary end points included patient satisfaction, time to adequate uterine tone, quantitative blood loss, postpartum hemorrhage (blood loss greater than 1000 mL), and safety measures (heart rate, blood pressure, phenylephrine dose, chest pain, nausea/vomiting, additional uterotonic use, and intensive care unit admission). RESULTS: Of 121 patients enrolled, 115 were analyzable (6 screen failures received no study drug); 114/115 received oxytocin per protocol. Baseline characteristics were similar between groups. Adequate uterine tone at 2 minutes (primary end point) was similar in bolus (50/60, 83.3%) vs infusion (43/55, 78.2%), P = .483. Patient satisfaction scores were also not significantly different (P = .495) between the two arms, with both the bolus and infusion arms having medians and interquartile range (IQRs) of (10 [IQR 10-10]). Median blood loss was slightly lower with bolus (558 mL [IQR 429-733]) vs infusion (687 mL [IQR 480-826], P = .0438; Hodges-Lehmann estimate of 82 mL [95% confidence interval {CI}, 2-168 mL]). Phenylephrine dosage and rates of postpartum hemorrhage, nausea, and additional uterotonic use were similar between groups (all P > .28). Rates of postpartum hemorrhage, hypotension, phenylephrine use, nausea, and additional uterotonic use were similar. CONCLUSIONS: There was no statistically significant difference in the frequency of achieving adequate uterine tone at 2 minutes between oxytocin given by infusion or bolus. Although the bolus group demonstrated statistically lower blood loss, the magnitude of this difference was small (upper confidence limit of 168 mL) and is unlikely to be clinically significant. Both methods showed comparable safety profiles.
引用
- Angelo TE, Daoud BE, Factor M, et al. Randomized Double-Blinded Clinical Trial of Oxytocin Bolus versus Infusion in Elective Cesarean (INBOX Trial). Anesth Analg. 2026. PMID: 42228946. doi:10.1213/ANE.0000000000008107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。